Skip to main content
Oncotarget logoLink to Oncotarget
. 2019 Jul 30;10(46):4802. doi: 10.18632/oncotarget.27101

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix

Minakshi Mann 1, Sachin Kumar 1, Shyam S Chauhan 2, Neerja Bhatla 3, Sunesh Kumar 3, Sameer Bakhshi 1, Ritu Gupta 4, Ashok Sharma 2,, Lalit Kumar 1,
PMCID: PMC6677665  PMID: 31413820

This article has been corrected: Dr. Ashok Sharma has been named as co-corresponding author on this paper, and has been moved from third place to second-to-last author in the listing.

The other correction, regarding funding, has already been made.

Original article: Oncotarget. 2019; 10:4262–4275. 4262-4275 . https://doi.org/10.18632/oncotarget.27008


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES